Literature DB >> 22231783

Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes.

Liana C Silva1, Oshrit Ben David2, Yael Pewzner-Jung2, Elad L Laviad2, Johnny Stiban2, Sibali Bandyopadhyay3, Alfred H Merrill3, Manuel Prieto4, Anthony H Futerman2.   

Abstract

Little is known about the effects of altering sphingolipid (SL) acyl chain structure and composition on the biophysical properties of biological membranes. We explored the biophysical consequences of depleting very long acyl chain (VLC) SLs in membranes prepared from lipid fractions isolated from a ceramide synthase 2 (CerS2)-null mouse, which is unable to synthesize C22-C24 ceramides. We demonstrate that ablation of CerS2 has different effects on liver and brain, causing a significant alteration in the fluidity of the membrane and affecting the type and/or extent of the phases present in the membrane. These changes are a consequence of the depletion of VLC and unsaturated SLs, which occurs to a different extent in liver and brain. In addition, ablation of CerS2 causes changes in intrinsic membrane curvature, leading to strong morphological alterations that promote vesicle adhesion, membrane fusion, and tubule formation. Together, these results show that depletion of VLC-SLs strongly affects membrane biophysical properties, which may compromise cellular processes that critically depend on membrane structure, such as trafficking and sorting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231783      PMCID: PMC3276466          DOI: 10.1194/jlr.M022715

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

Review 1.  Modulation of membrane traffic by mechanical stimuli.

Authors:  Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2002-02

2.  Nanotubular highways for intercellular organelle transport.

Authors:  Amin Rustom; Rainer Saffrich; Ivanka Markovic; Paul Walther; Hans-Hermann Gerdes
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

Review 3.  Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases.

Authors:  Meir Aridor
Journal:  Adv Drug Deliv Rev       Date:  2007-06-21       Impact factor: 15.470

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

5.  Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.

Authors:  Rolf G Boot; Marri Verhoek; Wilma Donker-Koopman; Anneke Strijland; Jan van Marle; Hermen S Overkleeft; Tom Wennekes; Johannes M F G Aerts
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

6.  Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.

Authors:  Elad L Laviad; Lee Albee; Irene Pankova-Kholmyansky; Sharon Epstein; Hyejung Park; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

Review 7.  Membrane lipids and vesicular traffic.

Authors:  Gerrit van Meer; Hein Sprong
Journal:  Curr Opin Cell Biol       Date:  2004-08       Impact factor: 8.382

Review 8.  The complex life of simple sphingolipids.

Authors:  Anthony H Futerman; Yusuf A Hannun
Journal:  EMBO Rep       Date:  2004-08       Impact factor: 8.807

Review 9.  Composition-driven surface domain structuring mediated by sphingolipids and membrane-active proteins. Above the nano- but under the micro-scale: mesoscopic biochemical/structural cross-talk in biomembranes.

Authors:  Bruno Maggio; Graciela A Borioli; Maximiliano Del Boca; Luisina De Tullio; María L Fanani; Rafael G Oliveira; Carla M Rosetti; Natalia Wilke
Journal:  Cell Biochem Biophys       Date:  2007-10-30       Impact factor: 2.194

Review 10.  Glycosphingolipid disorders of the brain.

Authors:  Stephanie D Boomkamp; Terry D Butters
Journal:  Subcell Biochem       Date:  2008
View more
  25 in total

Review 1.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

2.  Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.

Authors:  Woo-Jae Park; Joo-Won Park; Racheli Erez-Roman; Aviram Kogot-Levin; Jessica R Bame; Boaz Tirosh; Ann Saada; Alfred H Merrill; Yael Pewzner-Jung; Anthony H Futerman
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 3.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy.

Authors:  Ahmed Elsherbini; Erhard Bieberich
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 4.  Sphingolipids and mitochondrial apoptosis.

Authors:  Gauri A Patwardhan; Levi J Beverly; Leah J Siskind
Journal:  J Bioenerg Biomembr       Date:  2016-04       Impact factor: 2.945

5.  Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes.

Authors:  Sarah Brice Russo; Catalin F Baicu; An Van Laer; Tuoyu Geng; Harinath Kasiganesan; Michael R Zile; L Ashley Cowart
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

6.  Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis.

Authors:  Giora Volpert; Shifra Ben-Dor; Ohad Tarcic; Jingjing Duan; Ann Saada; Alfred H Merrill; Yael Pewzner-Jung; Anthony H Futerman
Journal:  J Cell Sci       Date:  2017-03-09       Impact factor: 5.285

Review 7.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

Review 8.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

9.  Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain.

Authors:  Hila Zigdon; Aviram Kogot-Levin; Joo-Won Park; Ruth Goldschmidt; Samuel Kelly; Alfred H Merrill; Avigdor Scherz; Yael Pewzner-Jung; Ann Saada; Anthony H Futerman
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

10.  Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.

Authors:  Richard L Klein; Samar M Hammad; Nathaniel L Baker; Kelly J Hunt; Mohammed M Al Gadban; Patricia A Cleary; Gabriel Virella; Maria F Lopes-Virella
Journal:  Metabolism       Date:  2014-07-09       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.